Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

Hangzhou Century Co Ltd A / Equity Bottom-Up

<ul>
 <li>Hangzhou Century is a key player in the Electronic Article Surveillance (EAS) and Radio Frequency Identification (RFID) markets, positioned to benefit from the growing need for retail loss prevention.</li>
 <li>Despite its established market position as the first listed EAS company in China, the company has faced significant financial challenges, reporting substantial net losses and declining revenues over the past three fiscal years.</li>
 <li>The company's valuation appears stretched, with key metrics like EV/Sales and Price-to-Book trading at a significant premium to peers, a concern amplified by its lack of profitability and high uncertainty.</li>
</ul>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


  Hangzhou Century is a key player in the Electronic Article Surveillance (EAS) and Radio Frequency Identification (RFID) markets, positioned to benefit from the growing need for retail loss prevention.
  Despite its established market position as the first listed EAS company in China, the company has faced significant financial challenges, reporting substantial net losses and declining revenues over the past three fiscal years.
  The company's valuation appears stretched, with key metrics like EV/Sales and Price-to-Book trading at a significant premium to peers, a concern amplified by its lack of profitability and high uncertainty.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: Hangzhou Century Co Ltd A (300078 CH) - Aug 2026

HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Thematic (Sector/Industry)

<a target="_blank"></a>In recent years, China digital healthcare industry has grown rapidly. The increasing cost of diseases and traditional medical treatment provides potential impetus for the long-term development of digital medicine. Especially during the epidemic, digital medical tools have helped people make full use of existing medical resources. Methods such as real-time epidemic information broadcast, Internet diagnosis and treatment platform, and remote drug purchase have all played an important role in the epidemic. Comprehensive intelligent digital healthcare treatment is gradually accepted and recognized by people, and will become the new direction of the development in the post-epidemic era (Related companies: <a href="https://www.smartkarma.com/entities/jd-health-international" target="_blank" data-smartkarma-citation="entities:29677:1" rel="noopener">JD Health (6618 HK)</a>, <a href="https://www.smartkarma.com/entities/alibaba-health-information-technology-ltd" target="_blank" data-smartkarma-citation="entities:453:1" rel="noopener">Alibaba Health Information Technology (241 HK)</a>, and <a href="https://www.smartkarma.com/entities/ping-an-healthcare-and-technology-company-limited" target="_blank" data-smartkarma-citation="entities:27008:1" rel="noopener">Ping An Healthcare and Technology Company Limited (1833 HK)).</a>

In recent years, China digital healthcare industry has grown rapidly. The increasing cost of diseases and traditional medical treatment provides potential impetus for the long-term development of digital medicine. Especially during the epidemic, digital medical tools have helped people make full use of existing medical resources. Methods such as real-time epidemic information broadcast, Internet diagnosis and treatment platform, and remote drug purchase have all played an important role in the epidemic. Comprehensive intelligent digital healthcare treatment is gradually accepted and recognized by people, and will become the new direction of the development in the post-epidemic era (Related companies: JD Health (6618 HK), Alibaba Health Information Technology (241 HK), and Ping An Healthcare and Technology Company Limited (1833 HK)).

Industry Report - Insights on China Digital Healthcare Industry

China

Hangzhou Century Co., Ltd. develops, manufactures, and sells anti-theft security products.  The Company's products include anti-theft tags, deactivators, decoders, detectors and other security screening devices.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Hangzhou Century Co Ltd A (300078 CH)

Primer: Hangzhou Century Co Ltd A (300078 CH) - Aug 2026

Hangzhou Century is a key player in the Electronic Article Surveillance (EAS) and Radio Frequency Identification (RFID) markets, positioned to...

αSK Primers

Industry Report - Insights on China Digital Healthcare Industry

The article analyzed China digital healthcare industry in terms of market potential, regional development, main business models(online...

Xinyao (Criss) Wang

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)